Lycopodium Limited (LYL)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $9.92
  • Currency: Australian Dollars
  • Shares Issued: 39.73m
Select chart: 1 month | 6 month
 

Current

1 month

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 379.00 67.70 117.00¢ 10.6 0.1 +181% 82.50¢ 0.0%
30-Jun-27 412.00 73.50 127.10¢ 9.8 1.1 +9% 87.50¢ 0.0%
30-Jun-28 428.00 78.50 135.80¢ 9.2 1.3 +7% 92.50¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-26 $9.54 1.30
30-Jun-27 $10.37 1.20
30-Jun-28 $10.77 1.15

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 379 n/a 379 n/a 379 n/a
30-Jun-2027 412 n/a 412 n/a 437 n/a
30-Jun-2028 428 n/a 428 n/a n/a n/a
 
Earnings
30-Jun-2026 117.00¢ n/a 117.00¢ n/a 117.90¢ n/a
30-Jun-2027 127.10¢ n/a 127.10¢ n/a 143.50¢ n/a
30-Jun-2028 135.80¢ n/a 135.80¢ n/a n/a n/a
 
Dividend
30-Jun-2026 82.50¢ n/a 82.50¢ n/a 95.00¢ n/a
30-Jun-2027 87.50¢ n/a 87.50¢ n/a 100.00¢ n/a
30-Jun-2028 92.50¢ n/a 92.50¢ n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 1 0 1 0 1 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 1 0 1 0 1 0
 
Average Rec 7.50 n/a 7.50 n/a 7.50 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

LYL Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $9.92
Shares Issued 39.73m

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page